U.S. Pharma Imports Soar in March as Drugmakers Look to Get Ahead of Potential Tariffs
Insmed Analyst Ratings
10 Health Care Stocks With Whale Alerts In Today's Session
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
Recent Report Shows That Rep. Jefferson Shreve Bought Up to $4.75M Worth of Apple Stock
8 Analysts Have This To Say About Natera
Natera Analyst Ratings
$100 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth This Much Today
Natera Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results and Raised Its FY25 Sales Guidance Above Estimates.
Natera GAAP EPS of -$0.50 Beats by $0.12, Revenue of $501.8M Beats by $55.13M
FDA to Speed up AI Rollout to Accelerate Drug Reviews
Insmed Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Earnings and Reaffirmed Full-year Guidance Below Estimates.
Argenx Plunges After Q1 Revenue Miss
Natera To Present Multiple Datasets In Breast Cancer Together With Collaborators At 2025 ESMO Breast Cancer Annual Congress In Munich
Here Are the Major Earnings After the Close Today
Marjorie Taylor Greene Goes Stock Shopping Again: Here Are 50+ Stocks The Congresswoman Bought
Here Are the Major Earnings Before the Open Tomorrow
Trump Planning on Executive Order to Further Cut Medicare Drug Prices - Report
What the Options Market Tells Us About Amgen
MHRA Approves Teprotumumab As The First UK Treatment For Adults With Moderate To Severe Thyroid Eye Disease